Blog

SCOTTSDALE, ARIZONA, UNITED STATES, May 17, 2023 / EINPresswire.com/ — Titan CEO and headline sponsor Wipfli LLP are pleased to announce Tara Franks, Chief Operating Officer of Translational Drug Development (TD2), as a 2023 Phoenix Titan 100. The Titan 100 program recognizes Phoenix’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished...

Read more +

SCOTTSDALE, ARIZONA, UNITED STATES, April 11, 2023/EINPresswire.com/ — Translational Drug Development (TD2), a precision oncology contract...

Read more +

NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage...

Read more +

NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) – SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...

Read more +

HUTCHINSON, Kan. – May 12, 2022 – Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Pharmaceuticals SA, announced today the...

Read more +

View More
Skip to content